Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
New England Journal of Medicine (2022) - Comments
doi: 10.1056/nejmoa2118542  issn: 0028-4793  issn: 1533-4406  pubmed: 35172054 

Jennifer Hammond, Heidi Leister-Tebbe, Annie Gardner, Paula Abreu, Weihang Bao, Wayne Wisemandle, MaryLynn Baniecki, Victoria M. Hendrick, Bharat Damle, Abraham Simón-Campos, Rienk Pypstra, James M. Rusnak